We are live on
!
Find out more
IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
32 hedge funds and large institutions have $7.54M invested in ImmunoCellular Therapeutics, Ltd. in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
152% more capital invested
Capital invested by funds: $2.99M → $7.54M (+$4.54M)
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
3% more funds holding
Funds holding: 31 → 32 (+1)
Holders
32
Holders Change
+1
Holders Change %
+3.23%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
10
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.7M |
| 2 |
AC
Armistice Capital
New York
|
+$1.55M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.24M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$425K |
| 5 |
Renaissance Technologies
New York
|
+$214K |
Top Sellers
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$99K |
| 2 |
CC
Callan Capital
La Jolla,
California
|
-$43.9K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$43K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$16.4K |
| 5 |
Morgan Stanley
New York
|
-$1.58K |
